Boirivant, M <br/><br/>
Oral administration of recombinant cholera toxin subunit B inhibits IL-12-mediated murine experimental (trinitrobenzene sulfonic acid) colitis.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  Mar 2001 
 - 3522-32 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-1767 
<br/><br/><label>Standard No.: </label>10.4049/jimmunol.166.5.3522  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Administration, Rectal<br/>Animals<br/>Apoptosis--immunology<br/>Cells, Cultured<br/>Cholera Toxin--administration & dosage<br/>Colitis--chemically induced<br/>Colon--immunology<br/>Disease Progression<br/>Interferon-gamma--biosynthesis<br/>Interleukin-10--biosynthesis<br/>Interleukin-12--antagonists & inhibitors<br/>Interleukin-4--biosynthesis<br/>Intestinal Mucosa--immunology<br/>Leukocytes, Mononuclear--immunology<br/>Male<br/>Mice<br/>Mice, Inbred Strains<br/>Oxazolone--administration & dosage<br/>Recombinant Proteins--administration & dosage<br/>Transforming Growth Factor beta--biosynthesis<br/>Trinitrobenzenesulfonic Acid--administration & dosage